Muhammad Absar
Impact in
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Chronic Myeloid Leukemia Treatments 5
-
- Antibiotic Resistance in Bacteria 6
- Co-authors
- Ali M. Somily (4 shared papers)Abdul Hannan (2 shared papers)Muhammad Ikram Ullah (1 shared paper)Thomas S. Murray (2 shared papers)Zahid Shakoor (2 shared papers)Yunus M. Siddiqui (1 shared paper)Amal J. Fatani (1 shared paper)Abiola Senok (1 shared paper)
- Journals
- Blood (2 papers)Saudi Journal of Biological Sciences (1 paper)Journal of Clinical Laboratory Analysis (1 paper)PLoS ONE (1 paper)Complementary Therapies in Clinical Practice (1 paper)
- Partner nations
- Saudi ArabiaPakistanMalaysia
In The Last Decade
Muhammad Absar
18 papers receiving 172 citations
Peers
Comparison fields: 5 of 63
- Molecular Medicine 65
- Applied Microbiology and Biotechnology 26
- Endocrinology 41
- Clinical Biochemistry 15
- Hematology 18
Countries citing papers authored by Muhammad Absar
This map shows the geographic impact of Muhammad Absar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad Absar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad Absar more than expected).
Fields of papers citing papers by Muhammad Absar
This network shows the impact of papers produced by Muhammad Absar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad Absar. The network helps show where Muhammad Absar may publish in the future.
Co-authors
The 25 scholars most cited alongside Muhammad Absar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Anti-mycobacterial activity of garlic (Allium sativum) against multi-drug resistant and non-multi-drug resistant mycobacterium tuberculosis. | 2011 | 45 |
| 2 | 2014 | 28 | |
| 3 | Antimicrobial susceptibility patterns of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii against carbapenems, colistin, and tigecycline. | 2012 | 26 |
| 4 | Antibiotic resistance among clinical isolates of Stenotrophomonas maltophilia at a teaching hospital in Riyadh, Saudi Arabia. | 2014 | 19 |
| 5 | 2022 | 10 | |
| 6 | 2016 | 9 | |
| 7 | 2017 | 8 | |
| 8 | In vitro activity of linezolid against clinical isolates of methicillin resistant Staphylococcus. | 2011 | 8 |
| 9 | 2015 | 7 | |
| 10 | 2021 | 6 | |
| 11 | 'Gastro' of Mirpur Khas (Sindh) is resolved. | 2009 | 5 |
| 12 | 2020 | 4 | |
| 13 | Whole exome sequencing identifies a novel FANCD2 gene splice site mutation associated with disease progression in chronic myeloid leukemia: Implication in targeted therapy of advanced phase CML. | 2020 | 4 |
| 14 | Thymic Stromal Lymphopoietin (TSLP) gene variant rs1837253 is significantly associated with Asthma prevalence in Pakistani Pashtun women. | 2020 | 3 |
| 15 | Phenotypic and molecular characterization of virulence factors of extra-intestinal pathogenic Escherichia coli isolated from patients of Peshawar, Pakistan. | 2021 | 3 |
| 16 | 2025 | 2 | |
| 17 | 2022 | 2 | |
| 18 | 2013 | 1 | |
| 19 | 2024 | 0 | |
| 20 | 2023 | 0 |
About Muhammad Absar
Muhammad Absar is a scholar working on Hematology, Molecular Medicine, Genetics, Endocrinology and Molecular Biology, having authored 25 papers that have together received 190 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (6 papers), Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Pharmaceutical and Antibiotic Environmental Impacts (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Bee Products Chemical Analysis (2 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers). The work is most often cited by research in Molecular Medicine (65 citations), Applied Microbiology and Biotechnology (26 citations), Endocrinology (41 citations), Clinical Biochemistry (15 citations) and Hematology (18 citations). Muhammad Absar has collaborated with scholars based in Saudi Arabia, Pakistan and Malaysia. Frequent co-authors include Ali M. Somily, Abdul Hannan, Muhammad Ikram Ullah, Thomas S. Murray, Zahid Shakoor, Yunus M. Siddiqui, Amal J. Fatani, Abdul Hannan, Abiola Senok and Zafar Iqbal. Their work appears in journals such as Blood, Saudi Journal of Biological Sciences, Journal of Clinical Laboratory Analysis, PLoS ONE and Complementary Therapies in Clinical Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.